An Evaluation of the Efficacy and Safety of CSF-1 in the Temporary Correction of Presbyopia (NEAR-2)
Clinical trial NCT04599972 · COMPLETED
Trial details
- NCT number
- NCT04599972
- Sponsor
- Orasis Pharmaceuticals Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-26
- Primary completion
- 2022-01-21
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.